Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants
Upon completion of this activity, you will be able to:
- list the commonly used commercial multigene assays utilized by oncologists for making therapy decisions.
- list the variables utilized in calculation of...
Back to Breast Cancers With Magee Equation Score of Less Than 18, or 18-25 and Mitosis Score of 1, Do Not Require Oncotype DX Testing: A Value Study
Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants
Upon completion of this activity, you will be able to:
- list the commonly used commercial multigene assays utilized by oncologists for making therapy decisions.
- list the variables utilized in calculation of Magee equations.
- correlate Magee equation scores and Oncotype DX recurrence score with the routinely reported pathology variables.
- analyze the algorithmic approach using Magee equations to safely withhold Oncotype DX testing in invasive breast cancer.